U.S. scientists were able to target tumor cells and inhibit melanoma and lung cancer in mice without causing side effects after orally administering lodamin, a drug derived from the Aspergillus fumigatus fresenius -- a fungus accidentally discovered while cultivating endothelial cells. The drug -- an angiogenesis inhibitor developed through nanotechnology -- may prove useful in treating other cancers and conditions characterized by irregular blood vessel growth, the researchers said.

Full Story:

Related Summaries